http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Safe & Green Holdings Announces Equity Line of Credit with Alumni Capital to Accelerate Growth through Shareholder-Friendly Funding Mechanism
-
Innovative Algorithm Slashes Time to Solve Massive Optimization Problems
-
Safe & Green Holdings Announces Equity Line of Credit with Alumni Capital to Accelerate Growth through Shareholder-Friendly Funding Mechanism
-
Krispy Krunchy Chicken® Finishes 2024 with Over 600 Openings
-
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
-
Amazon, Nvidia and University of California to Keynote 30th Edition of DesignCon
-
Mainz Biomed (MYNZ) Regains Nasdaq Compliance
-
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
-
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
-
Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer
-
Pacific Ridge Raising $2.4M to Explore Portfolio of U.S. Copper and Gold Projects
-
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Ontario International Airport wins 6 digital marketing awards
-
Stoopid Cats Revolutionizes P2E Gaming: 100K Players, $250K Raised, and Dividend NFTs
-
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
-
Stoopid Cats Revolutionizes P2E Gaming: 100K Players, $250K Raised, and Dividend NFTs
-
Applebee’s Guests Can Score Big with 20 FREE Boneless Wings on Super Bowl Sunday
-
Juniper Networks Announces Juniper Partner Advantage 2025 to Accelerate Partner Growth and Profitability
-
Mawson Infrastructure Group Releases Updated Company Presentation – 136% Y/Y Revenue Growth in Digital Colocation Business, 36% Y/Y Revenue Growth in Total Revenue, and 31% Y/Y Operating Hash Rate G
-
Anavex Life Sciences (AVXL) Announces Issuance of Blarcamesine Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
-
Trinity Capital Inc. Provides $30 Million in Growth Capital to Elucent Medical
-
Leslie’s, Inc. to Report First Quarter Fiscal 2025 Financial Results on February 6, 2025
-
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
-
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
-
Adagene Inc. (ADAG) Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA
-
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
-
Qmerit, Wisetack Enter Partnership to Give EV Buyers Greater Flexibility in Financing Home Charging
-
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
-
Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
-
Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis
-
GT Resources Samples 8.2% Copper and Identifies BHEM Conductors at the North Rock Copper-Nickel-PGE Project, Ontario, Canada
-
FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)
-
Frontera Announces Preliminary Results of Substantial Issuer Bid
-
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
-
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
-
Children’s Hospital Los Angeles Adds Transformative Gene Therapy and Expands to 10 Treatments, Becoming the Largest Provider of Pediatric Cell and Gene Therapies on the West Coast
-
ACUD TRIUMPHS AT GLOBAL BRAND AWARDS 2024
-
Emeric Nectoux: A Visionary Photographer Capturing Beauty and Stories
-
China's DeepSeek sparks AI market rout
-
xLocums Names Alicia Calloway Executive Director to Lead Locum Tenens Staffing Expansion
-
Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD
-
PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Block, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SQ, XYZ
-
ROSEN, A TOP RANKED LAW FIRM, Encourages DMC Global Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BOOM
-
ROSEN, A TOP-RANKED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Capri Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - CPRI
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Innovative Industrial Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- IIPR
-
ROSEN, A TOP-RANKED LAW FIRM, Encourages Dave Inc. Investors to Inquire About Securities Class Action Investigation - DAVE
-
ROSEN, A TOP-RANKED LAW FIRM, Encourages Nextracker, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NXT
